IPHA
Price
$2.38
Change
-$0.00 (-0.00%)
Updated
May 8 closing price
Capitalization
211.13M
4 days until earnings call
SLNO
Price
$76.26
Change
+$1.60 (+2.14%)
Updated
May 8 closing price
Capitalization
3.73B
89 days until earnings call
Ad is loading...

IPHA vs SLNO

Header iconIPHA vs SLNO Comparison
Open Charts IPHA vs SLNOBanner chart's image
Innate Pharma SA
Price$2.38
Change-$0.00 (-0.00%)
Volume$121.77K
Capitalization211.13M
Soleno Therapeutics
Price$76.26
Change+$1.60 (+2.14%)
Volume$2.16M
Capitalization3.73B
IPHA vs SLNO Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. SLNO commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and SLNO is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (IPHA: $2.38 vs. SLNO: $76.26)
Brand notoriety: IPHA and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 450% vs. SLNO: 138%
Market capitalization -- IPHA: $211.13M vs. SLNO: $3.73B
IPHA [@Biotechnology] is valued at $211.13M. SLNO’s [@Biotechnology] market capitalization is $3.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, IPHA is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 7 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • IPHA’s TA Score: 7 bullish, 3 bearish.
  • SLNO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than SLNO.

Price Growth

IPHA (@Biotechnology) experienced а +7.45% price change this week, while SLNO (@Biotechnology) price change was +1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

IPHA is expected to report earnings on May 13, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.73B) has a higher market cap than IPHA($211M). SLNO YTD gains are higher at: 69.655 vs. IPHA (29.348).
IPHASLNOIPHA / SLNO
Capitalization211M3.73B6%
EBITDAN/A-173.63M-
Gain YTD29.34869.65542%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A291M-
Total DebtN/A52.8M-
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHASLNO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RESGX14.960.08
+0.54%
Glenmede Environmental Accountability
JRSCX10.850.05
+0.46%
JH Adaptive Risk Mgd U.S. Eq C
GSTTX12.45N/A
N/A
Goldman Sachs Strategic Growth Inv
MSTQX12.32N/A
N/A
Morningstar US Equity
MKVEX14.88N/A
N/A
MFS International Large Cap Value R2